Published in Mol Neurobiol on August 17, 2016
Essential Roles of E3 Ubiquitin Ligases in p53 Regulation. Int J Mol Sci (2017) 0.77
SHARPIN Facilitates p53 Degradation in Breast Cancer Cells. Neoplasia (2017) 0.75
p53 mutations in human cancers. Science (1991) 31.96
Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev (2007) 17.20
cop1: a regulatory locus involved in light-controlled development and gene expression in Arabidopsis. Genes Dev (1991) 5.64
The ubiquitin ligase COP1 is a critical negative regulator of p53. Nature (2004) 5.05
Insulin modulates gluconeogenesis by inhibition of the coactivator TORC2. Nature (2007) 4.54
Human De-etiolated-1 regulates c-Jun by assembling a CUL4A ubiquitin ligase. Science (2004) 3.28
TRB3 links the E3 ubiquitin ligase COP1 to lipid metabolism. Science (2006) 3.26
The p53 functional circuit. J Cell Sci (2001) 2.46
COP1 is a tumour suppressor that causes degradation of ETS transcription factors. Nature (2011) 1.83
ATM engages autodegradation of the E3 ubiquitin ligase COP1 after DNA damage. Science (2006) 1.64
Cop1 constitutively regulates c-Jun protein stability and functions as a tumor suppressor in mice. J Clin Invest (2011) 1.59
Characterization of human constitutive photomorphogenesis protein 1, a RING finger ubiquitin ligase that interacts with Jun transcription factors and modulates their transcriptional activity. J Biol Chem (2003) 1.42
COP1, the negative regulator of p53, is overexpressed in breast and ovarian adenocarcinomas. Cancer Res (2004) 1.35
E3 ubiquitin ligase COP1 regulates the stability and functions of MTA1. Proc Natl Acad Sci U S A (2009) 1.28
Glioma therapy in adults. Neurologist (2006) 1.26
Malignant gliomas in adults. N Engl J Med (2008) 1.19
COP1 functions as a FoxO1 ubiquitin E3 ligase to regulate FoxO1-mediated gene expression. J Biol Chem (2008) 1.16
14-3-3sigma exerts tumor-suppressor activity mediated by regulation of COP1 stability. Cancer Res (2010) 1.11
Spotlight on the role of COP1 in tumorigenesis. Nat Rev Cancer (2012) 1.06
Definition of ubiquitination modulator COP1 as a novel therapeutic target in human hepatocellular carcinoma. Cancer Res (2010) 1.05
Myeloid leukemia factor 1 regulates p53 by suppressing COP1 via COP9 signalosome subunit 3. EMBO J (2005) 1.04
COP1D, an alternatively spliced constitutive photomorphogenic-1 (COP1) product, stabilizes UV stress-induced c-Jun through inhibition of full-length COP1. Oncogene (2007) 1.01
Phosphorylation of ETS1 by Src family kinases prevents its recognition by the COP1 tumor suppressor. Cancer Cell (2014) 0.99
Interplay between MDM2, MDMX, Pirh2 and COP1: the negative regulators of p53. Mol Biol Rep (2010) 0.96
Role of p53 in Cell Death and Human Cancers. Cancers (Basel) (2011) 0.95
COP1 and GSK3β cooperate to promote c-Jun degradation and inhibit breast cancer cell tumorigenesis. Neoplasia (2013) 0.94
Good COP1 or bad COP1? In vivo veritas. J Clin Invest (2011) 0.87
COP1 enhances ubiquitin-mediated degradation of p27Kip1 to promote cancer cell growth. Oncotarget (2015) 0.84
CacyBP/SIP protein is important for the proliferation of human glioma cells. IUBMB Life (2014) 0.81
Nrdp1S, short variant of Nrdp1, inhibits human glioma progression by increasing Nrdp1-mediated ErbB3 ubiquitination and degradation. J Cell Mol Med (2015) 0.81
High level of COP1 expression is associated with poor prognosis in primary gastric cancer. Int J Biol Sci (2012) 0.79
COP1, the negative regulator of ETV1, influences prognosis in triple-negative breast cancer. BMC Cancer (2015) 0.79
Therapy for recurrent malignant glioma in adults. Expert Rev Anticancer Ther (2004) 0.78
Ubiquitin ligase Siah1 promotes the migration and invasion of human glioma cells by regulating HIF-1α signaling under hypoxia. Oncol Rep (2014) 0.77